Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

Concordia University

$25,000.00

Mircrofluidic assembly of dual enzyme and oxidation-responsive polyesters

EF 2016-17

Résumé
Current nanotechnology, drawing from research in polymer chemistry, has focused on the development ofmultifunctional nanoscale devices that have potential for research in medicines and pharmaceutical science.Well-defined polymer-based drug delivery systems have drawn significant attention because of theirapplications in targeting tumors. Further, their ability to controlled and enhanced release of encapsulated drugsin response to cellular and tumor components maximize drug efficacy and minimize side effects common tosmall drugs, thus offering versatility in tumor-targeting controlled/enhanced drug delivery applications. Thechallenge for successful clinical applications is to develop an effective method to well-defined drug-loadednanocarriers that is economical for large production.Precision NanoSystems, a Canadian-based, rapidly-growing enterprise located in Vancouver, develops newnanoparticle delivery technologies via miniature microfluidics. The technology allows for rapid mixing on asmall scale for reproducible control over particle formation. This effective collaboration having complementaryexpertise in unique microfluidic technique and experienced drug delivery will enable the development of novelnanomedicines exhibiting dual stimuli-responsive enhanced drug release for cancer therapy, ultimately offeringa great potential to improve quality of life for all Canadians. Further, the output obtained from thiscollaborative research will allow the company to be competitive in customer markets over other globalcompanies in aspects of technology and service to customers.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
506177-2016
Name nom
Oh, JungKwon
Department département
Chemistry and Biochemistry
Organization id
70
Institution établissement
Concordia University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
3750
Research subject group en
Polymer chemistry
Research subject group fr
Chimie des polymères
Research subject en
Polymer chemistry
Research subject fr
Chimie des polymères
Partie
1
Nb partie
1
Application title
Mircrofluidic assembly of dual enzyme and oxidation-responsive polyesters
Keyword
NSERC
Application summary
Current nanotechnology, drawing from research in polymer chemistry, has focused on the development ofmultifunctional nanoscale devices that have potential for research in medicines and pharmaceutical science.Well-defined polymer-based drug delivery systems have drawn significant attention because of theirapplications in targeting tumors. Further, their ability to controlled and enhanced release of encapsulated drugsin response to cellular and tumor components maximize drug efficacy and minimize side effects common tosmall drugs, thus offering versatility in tumor-targeting controlled/enhanced drug delivery applications. Thechallenge for successful clinical applications is to develop an effective method to well-defined drug-loadednanocarriers that is economical for large production.Precision NanoSystems, a Canadian-based, rapidly-growing enterprise located in Vancouver, develops newnanoparticle delivery technologies via miniature microfluidics. The technology allows for rapid mixing on asmall scale for reproducible control over particle formation. This effective collaboration having complementaryexpertise in unique microfluidic technique and experienced drug delivery will enable the development of novelnanomedicines exhibiting dual stimuli-responsive enhanced drug release for cancer therapy, ultimately offeringa great potential to improve quality of life for all Canadians. Further, the output obtained from thiscollaborative research will allow the company to be competitive in customer markets over other globalcompanies in aspects of technology and service to customers.